Cargando…
Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation
BACKGROUND: Bisacodyl is a member of the diphenylmethane family and is considered to be a stimulant laxative. It has a dual prokinetic and secretory action and needs to be converted into the active metabolite bis‐(p‐hydroxyphenyl)‐pyridyl‐2‐methane (BHPM) in the gut to achieve the desired laxative e...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596401/ https://www.ncbi.nlm.nih.gov/pubmed/33751780 http://dx.doi.org/10.1111/nmo.14123 |